The global Vertebroplasty Kyphoplasty Needles Market had a valuation of USD 702 million in 2022, and it is projected to reach USD 1028 million by the year 2032. This growth trajectory is set to maintain a compound annual growth rate (CAGR) of 4.7% throughout the forecast period. The surge in market revenue can be attributed to several factors, including the escalating prevalence of conditions like osteoporosis and spinal fractures, the upward trend in the aging population, and advancements in minimally invasive surgical techniques.
The treatment of spinal fractures has been revolutionized by the emergence of minimally invasive surgical procedures like vertebroplasty and kyphoplasty. These techniques involve the injection of bone cement into fractured vertebrae, thereby stabilizing the bone and alleviating discomfort. The administration of this bone cement is facilitated through specialized needles during the vertebroplasty and kyphoplasty procedures.
Get a free sample PDF of the report, visit @ https://www.reportsanddata.com/download-free-sample/7440
The principal driver of the growth in revenue for the vertebroplasty and kyphoplasty needles market is the escalating incidence of osteoporosis and spinal fractures. A staggering 200 million women worldwide are estimated to be affected by osteoporosis, resulting in over 8.9 million fractures annually, according to the International Osteoporosis Foundation. Moreover, spinal fractures, constituting about 1.4 million cases per year globally, stand as the most prevalent form of osteoporotic fractures.
The expanding elderly population stands as another significant factor propelling market revenue growth. The heightened susceptibility to osteoporosis and spinal fractures associated with aging has led to an amplified demand for minimally invasive surgical options such as vertebroplasty and kyphoplasty. The United Nations predicts that the global population aged 60 and above will burgeon from 962 million in 2017 to 2.1 billion by 2050.
The progress in minimally invasive surgical techniques is also instrumental in bolstering the market revenue. Compared to traditional open surgeries, these techniques are less intrusive, resulting in reduced hospital stays, decreased postoperative discomfort, and quicker recovery periods. Innovations in imaging technologies like fluoroscopy and ultrasound have enhanced the precision and safety of these procedures.
Nevertheless, the growth in vertebroplasty and kyphoplasty needles market revenue is not devoid of challenges. The high cost associated with these procedures can potentially discourage individuals from seeking treatment. The availability of alternative therapies like painkillers and physical therapy might also curtail the demand for vertebroplasty and kyphoplasty surgeries.
Regulatory bodies play a crucial role in overseeing these procedures. In the United States, the Food and Drug Administration (FDA) regulates all medical devices used in vertebroplasty and kyphoplasty, including needles. Similarly, the European Union has set forth regulations to ensure the safety and performance of medical devices.
To know more about the latest insights of the report, visit @
https://www.reportsanddata.com/request-latest-insight/7440
The World Health Organization has issued guidelines for the safe use of medical devices in these procedures. Many countries have introduced legislation mandating comprehensive product information before marketing or selling. Age restrictions on certain needle types and limits on purchase quantity have also been implemented in some regions.
The market for vertebroplasty and kyphoplasty needles encompasses various product types, including bone cement needles, aspiration needles, biopsy needles, and specialized needles like radiofrequency ablation needles. The bone cement needles category held a substantial revenue share in 2022 due to the increasing prevalence of osteoporosis and the subsequent demand for surgeries. Aspiration needles are anticipated to witness significant growth, while biopsy needles and specialized needles are expected to experience moderate and modest revenue increases, respectively.
These procedures primarily target vertebral compression fractures caused by osteoporosis, malignancy, or trauma. Vertebroplasty involves injecting bone cement to stabilize the fracture and alleviate pain. Kyphoplasty, on the other hand, uses a balloon catheter to restore vertebral height before cement injection. Both procedures have shown high success rates in pain reduction and mobility improvement.
North America is expected to dominate the market, driven by high osteoporosis rates and the adoption of minimally invasive techniques. The Asia Pacific region is poised for considerable growth due to increasing demand for minimally invasive procedures and an aging population. Europe is anticipated to see moderate growth, attributed to rising osteoporosis rates and increasing awareness of less invasive options.
In this niche market, major players include Stryker Corporation, Cook Medical, Boston Scientific Corporation, Terumo Corporation, Medtronic plc, BD (Becton, Dickinson and Company), JJ (Johnson Johnson), and Globus Medical. The market's steady growth is supported by the prevalence of osteoporosis and bone-related diseases, coupled with an aging global population. Continued technological advancements are expected to further enhance the effectiveness of these procedures, expanding their potential patient base.
Request a customized copy of the report @ https://www.reportsanddata.com/request-customization-form/7440
Thank you for reading our report. To inquire about customization or any query about the report, please get in touch with us. Our team will make sure the report is best suited to your needs.
Browse for more reports:
Healthcare Personal Protective Equipment (PPE) Market
About Reports and Data
Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients to make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Products, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.
Contact Us:
John W
(Head of Business Development)
Reports and Data | Web: www.reportsanddata.com
Direct Line: +1-212-710-1370
E-mail: sales@reportsanddata.com
Blogs | Press Release | Industry News | Our competencies
Browse More Upcoming Reports @ https://www.reportsanddata.com/upcoming-reports
Browse More Latest Reports @ https://www.reportsanddata.com/report
